S&P 500 7,323.63 −0.23%
Nasdaq 24,429.89 +0.42%
S&P/TSX 34,578.05 −2.09%
Apple 352.45 +0.15%
Nvidia 150.96 −2.89%
Microsoft 508.29 +0.40%
Shopify 199.78 −1.50%
Royal Bank 272.26 −3.11%
CAD/USD 0.6994 +0.01%
PRE-MKT · 05:45 ET
Market ClerkRecap
Thu Nov 19 · pre-market7 signals on Nov 18520 insider buys this week · $248.1MCIRO short report next: Nov 30The week ahead
MN
INSIDER · KYMR · Kymera Therapeutics, Inc. · CHIEF EXECUTIVE OFFICER

Mainolfi Nello

Every open-market transaction filed under this name, Oct 1 to Oct 1.

Filings
6
0 buys · 6 sells
Bought
—
open market, at cost
Sold
$3.4M
includes scheduled sales
Buys since
—
no current price on file

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Oct 1KYMRKymera Therapeutics, Inc.Chief Executive OfficerSell262$116.12$30K—
Oct 1KYMRKymera Therapeutics, Inc.Chief Executive OfficerSell8,230$115.40$950K—
Oct 1KYMRKymera Therapeutics, Inc.Chief Executive OfficerSell7,601$114.43$870K—
Oct 1KYMRKymera Therapeutics, Inc.Chief Executive OfficerSell4,876$113.24$552K—
Oct 1KYMRKymera Therapeutics, Inc.Chief Executive OfficerSell5,506$112.42$619K—
Oct 1KYMRKymera Therapeutics, Inc.Chief Executive OfficerSell3,525$111.44$393K—

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.